gain in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... months of 2009 also includes the $171.8 million gain that Isis recognized on the sale net of taxes. A ... strategic alliance with Genzyme in 2008 and the gain it recognized on the sale of Ibis to AMI earlier ... operations also included a $2.5 million gain on investments that Isis recognized in the second ...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

... adverse events observed in adolescents. Weight gain was greatest in adolescents who were overweight ... when they began treatment. Significant weight gain was also observed in patients who were of normal ... in adolescents than adults. "Because weight gain and some of the metabolic changes are more likely ...

Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain and Hypoglycemia Risk for Diabetes Patients

... and also results in significantly less weight gain and risk of hypoglycemia for adult patients with ... levels with the added benefits of less weight gain and lower risk of hypoglycemia." AFRESA is a ... TI+G produced significantly less weight gain (0.9 vs. 2.5 kg; p=0.0002) and significantly less ...

SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results

... loss was primarily due to the $4.0 million net gain from the termination of the lease on our ... premises. We recognized in operating expense, the gain of $4.1 million and $116,867 of expense related ... operating expenses were primarily due to the net gain of $4.0 million from the lease termination and ...

Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby

... that weighs 9 pounds or more. "Too many women gain too much weight during pregnancy. This ... and recently have learned how maternal weight gain affects the birth weight, this is the first study to determine that women who gain excessive weight are even more likely to have ...

Behavioral Modification Programs Help Obese Children Manage Their Weight

... teens can lose weight or prevent further weight gain if they participate in medium- to high-intensity ... programs out there that can help kids to either gain weight more slowly as they grow or, where ... of 14 pounds, compared with a 4.2-pound weight gain among those who took a placebo. In another ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

... 5,078 21,432 12,165 36,948 gain on sale of intangible asset 36,397 - ... (451) (1,271) (1,248) (2,899) gain on extinguishment of debt 6,991 - ... - (1,853) - (2,991) gain on sale of subsidiary - 78,352 ...

Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin

... goals of improved glucose control without weight gain or hypoglycemia compared to the use of ... study, with SYMLIN use resulting in no weight gain and less hypoglycemia." The study was designed ... achieving a target A1C and experiencing no weight gain or episodes of severe hypoglycemia. Among those ...

Women Who Gain Excessive Weight During Pregnancy More Likely to Have Overweight Children

... during intrauterine life, and gestational weight gain may influence the environment in the womb in ways ... of Pennsylvania. "Adherence to pregnancy weight gain recommendations may be a new and effective way ... time of delivery to determine gestational weight gain - the difference between the measured weight at ...

Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission

... gastrointestinal surgery. Patients from CHARM and gain were followed through into a ... total of two years, and patients from the 4-week gain study were followed a total of one year. The ... clinical remission for an additional year. The gain data showed that, of patients with a clinical ...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

... a mean weight loss of 5.8 pounds at 26 weeks, compared with a mean weight gain of 3.1 pounds for Lantus, a difference of 8.9 pounds between the ... significantly greater A1C reduction, weight loss versus weight gain and fewer episodes of hypoglycemia." More than 90 percent of ...

Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)

... include, but are not limited to, whether or when the Companies are able to gain FDA approval of the Acurox(R) Tablets NDA; whether additional clinical ... approval of the Acurox(R) Tablets NDA; whether or when the Companies may gain FDA approval of product labeling for the proposed indication or for abuse ...

Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program

... exceptional scientists, perform hands-on, laboratory-based research and gain the practical knowledge necessary to succeed in their area of research, ... them to Roskamp's state-of-the-art technology and will allow them to gain knowledge of the Institute's key divisions, including chemistry, ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... common side effects in the treatment of Bipolar I Disorder were weight gain (when used alone) and tremors (when used with other medications). If ... Gain: In a 12-week trial, the percentage of patients experiencing weight gain (>7% of baseline body weight) was 6% placebo versus 9% RISPERDAL(R) ...

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

... share) for 2007. The decreased net loss for 2008 was due primarily to a gain on the sale of CoGenesys stock of $32.5 million ($0.24 per share), ... (235) - (6,284) - gain on sale of long-term equity investment - - ...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... commercialized; whether Vical or its collaborative partners will seek or gain approval to market the influenza vaccine or any other product candidates; ... clinical trials; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; and additional risks set forth ...

Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation

... profile in clinical trials or could take a significantly longer time to gain regulatory approval than Dyax expects or may never gain approval; products developed in this collaboration may not gain market ...

MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes

... patients experiencing hypoglycemic events * Weight loss versus weight gain * No adverse effects on pulmonary function Dr. Peter Richardson, ... kg (4.3 pounds) over the 52-week treatment period compared to the average gain of 1.4 kg (3.0 pounds) observed in the comparator group. This difference ...

August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam

... says Robert Sheeler, M.D., a family physician at Mayo Clinic. To gain the health benefits, there's no need to eat a whole chocolate bar. After ... about 30 calories worth, will provide the health benefits. Generally, to gain health benefits, Dr. Sheeler recommends chocolate that contains at least ...

Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program

... showed no change in weight compared to baseline, while a weight gain (1.4 +/- 2.9 kg) was seen in the patients (n=108) receiving Humulin(R) R ... a weight reduction (-0.5 +/- 4.7 kg) compared to baseline, while a weight gain (0.8 +/- 6.2 kg) was seen in the patients (n=180) receiving Humulin(R) R ...

Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference

... oral olanzapine except for injection-related events. Incidence of weight gain of 7 percent or more from baseline was significantly higher for ... have been observed with olanzapine use. Potential consequences of weight gain should be considered prior to starting olanzapine. Patients receiving ...

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation

... into agreements to vote in favour of the combination. Intercell will gain full rights to Iomai's late stage Travelers' Diarrhea vaccine which is ... shareholders, employees and ultimately patients." Intercell will also gain full rights to two additional clinical and three preclinical programs ...

Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting

... trial, asenapine had a lower incidence of clinically significant weight gain (15%) vs olanzapine (36%)." Presentation of the overview of the Olympia ... both treatment groups were insomnia, worsening psychotic symptoms, weight gain and depression. Additional Asenapine Data Presentations Additional ...

Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study

... RLAI and in six percent of the patients in the quetiapine group. Weight gain was observed in both treatment arms with no statistically significant ... in changes in body weight or BMI versus baseline (seven percent weight gain for RLAI versus 6.2 percent for quetiapine). Potentially prolactin-related ...

PLC Systems Reports Fourth Quarter 2007 Results

... per diluted share, in 2006, a period that also included a $1.4 million gain on the sale of PLC's Optiwave disposable manufacturing rights to ... expenses 1,573 1,083 6,176 4,938 gain on the sale of manufacturing rights - - - ...

AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

... (5% vs 1%), dyspepsia (5%-7% vs 1%-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The most commonly observed adverse events associated with the ... 3%), postural hypotension (7% vs 2%), pharyngitis (6% vs 3%), and weight gain (6% vs 3%). The most commonly observed adverse events associated with the ...

PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting

... practice in the southeastern United States, was conducted to gain a better understanding of the demographics, real-world treatment ... practice in the southeastern United States was conducted to gain a better understanding of real- world treatment patterns and clinical ...

SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia

... (5% vs 1%), dyspepsia (5%-7% vs 1%-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The most commonly observed adverse events associated with the ... 3%), postural hypotension (7% vs 2%), pharyngitis (6% vs 3%), and weight gain (6% vs 3%). The most commonly observed adverse events associated with the ...

DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study

... with major depressive disorder that can be exacerbated by the weight gain produced by many antidepressants. We believe a product that could not only manage depression but also impact weight gain would represent a significant advantage over currently marketed ...

Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint

... use in all autologous transplant procedures. We will work aggressively to gain regulatory approval in these transplant settings, while also pressing ... favoring use of Mozobil, Genzyme's ability to work aggressively to gain regulatory approval, Genzyme's ability to unlock the full potential of ...

Regular Yoga Practice Is Associated With Mindful Eating

... or running, and mindful eating. "These findings fit with our hypothesis that yoga increases mindfulness in eating and leads to less weight gain over time, independent of the physical activity aspect of yoga practice," said Kristal, who is also a professor of epidemiology at the University of ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... with an improvement by the first week of therapy in "overall quality of sleep" and "awakening during the night". The incidence of agitation, weight gain and sexual dysfunction in patients administered Labopharm's trazodone was no different from placebo. The overall drop out rate in the study was 25 ...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... Capital lease obligations 19,616 20,347 Deferred revenue 52,696 55,567 Deferred gain 5,463 5,901 Other long-term liabilities 4,354 5,238 ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... or diabetes, such as being thirsty all the time, having to urinate or "pass urine" more often than usual, or feeling weak or hungry. Weight gain has been observed with INVEGA((R)) SUSTENNA(TM) and other atypical antipsychotic medications. If you notice that you are gaining weight, please ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... neurology, metabolism, parasitology, growth and development and cancer. Along with his colleagues, Dr. Jacob's team hopes to use knockout rats to gain a better understanding of disease processes related to hypertension, heart disease, kidney failure and cancer. ZFNs are engineered proteins ...

Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

... from those indicated by these forward-looking statements, including, without limitation, that Cardica's current and any future products may never gain any significant degree of market acceptance, that any future Cardica products face regulatory, reimbursement and manufacturing risks, that Cardica's ...

Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program

... Development. "The abiding mission at Velos has always been to promote the NCI and its objectives. We're committed to facilitating their efforts to gain needed, up-to-date information. We have a shared goal to optimize investment in cancer research." Recently, the NCI formalized the ...

5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

... (11.1% vs 7.6% respectively, p=0.0439) and mean yearly rates of symptomatic hypoglycemia (7.08+/-16.49 vs 5.13+/-12.79, p=0.0017). Body weight gain tended to be greater with NPH insulin compared with insulin glargine treatment, with a baseline to endpoint increase in mean body weight of 3.7 kg ...

Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs

... to submitting a formal Investigational New Drug (IND) application to the FDA to begin clinical trials in SMA Type I. It is the intent of CSC to gain approval to begin FDA-approved clinical trials for the use of these cells in development of a cell replacement therapy for SMA Type I. Numerous ...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

... contractual obligations of third parties in the clinical trials, manufacturing, marketing, sales and distribution of its products; orBec(R) may not gain market acceptance if it is eventually approved by the FDA; and others may develop technologies or products superior to orBec(R). These and other ...